Jiang, D., Wang, H., Li, Z., Li, Z., Chen, X., & Cai, H. (2016). MiR-142 inhibits the development of cervical cancer by targeting HMGB1. Oncotarget.
Chicago-stil citatJiang, Daqiong, Huiyan Wang, Zhuyan Li, Zhen Li, Xin Chen, och Hongbing Cai. "MiR-142 Inhibits the Development of Cervical Cancer By Targeting HMGB1." Oncotarget 2016.
MLA-referensJiang, Daqiong, et al. "MiR-142 Inhibits the Development of Cervical Cancer By Targeting HMGB1." Oncotarget 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.